SARAH BUSH LINCOLN HEALTH CENTER

45 CFR § 180 compliance

B · 85

This hospital published most of what § 180 requires.

●Machine-readable file published

●Gross / standard charges

●Discounted cash price

●Payer-specific negotiated rates

○Min / max negotiated charges

●Free, public, no login required

Procedures listed

5,925

Insurances with rates

CPT / HCPCS codes

Source MRF

csv ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
10022165_1	INJECTION, VUTRISIRAN, 1 MG	$630,773	$630,773	—	—	46
10105078_1	INJECTION, PEGLOTICASE, 1 MG	$123,087	$123,087	—	—	46
10016945_1	LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, THERAPEUTIC, 1 MILLICURIE	$119,074	$119,074	—	—	46
10048137_1	INJECTION, TARLATAMAB-DLLE, 1 MG	$96,480	$96,480	—	—	41
10016785_1	JOINT DEVICE (IMPLANTABLE)	$91,410	$91,410	—	—	28
10102746_1	INJECTION, EFGARTIGIMOD ALFA, 2 MG AND HYALURONIDASE-QVFC	$84,891	$84,891	—	—	41
10182280_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT	$69,209	$69,209	—	—	41
10017528_10	INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG	$59,749	$59,749	—	—	46
10017528_3	INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG	$59,749	$59,749	—	—	25
10099876_1	INJECTION, GUSELKUMAB, 1 MG	$57,862	$57,862	—	—	46
10063778_1	INJECTION, UBLITUXIMAB-XIIY, 1MG	$55,895	$55,895	—	—	46
10116238_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chambe	$54,707	$54,707	—	—	46
10149093_1	ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE)	$54,155	$54,155	—	—	28
10116239_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial	$50,616	$50,616	—	—	46
10116240_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial	$50,616	$50,616	—	—	46
10116241_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial	$50,616	$50,616	—	—	46
10116242_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial	$50,616	$50,616	—	—	46
10139899_1	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), HIGH FREQUENCY, WITH RECHARGEABLE BATTERY AND CHARGING SYS	$50,084	$50,084	—	—	28
10143417_1	CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE)	$49,683	$49,683	—	—	28
10100228_1	INJECTION, SODIUM THIOSULFATE (PEDMARK), 100 MG	$47,292	$47,292	—	—	46
10182279_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT	$47,237	$47,237	—	—	41
10180289_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH	$46,173	$46,173	—	—	41
10013434_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE	$44,923	$44,923	—	—	46
10116254_1	Insertion of permanent single-chamber leadless pacemaker for pacing the right upper heart chamber us	$44,706	$44,706	—	—	41
10182282_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH	$44,040	$44,040	—	—	41
10021172_1	CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)	$42,816	$42,816	—	—	28
10024626_1	CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA)	$42,771	$42,771	—	—	28
10115625_1	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM	$41,268	$41,268	—	—	28
10138675_1	CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)	$41,265	$41,265	—	—	28
10113333_1	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), INCLUDES CLOSED FEEDBACK LOOP LEADS AND ALL IMPLANTABLE CO	$41,068	$41,068	—	—	28
10120786_1	CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)	$40,764	$40,764	—	—	28
10112064_1	IMPLANTABLE NEUROSTIMULATOR, PULSE GENERATOR, ANY TYPE	$40,066	$40,066	—	—	41
10017527_10	INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG	$39,833	$39,833	—	—	46
10017527_3	INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG	$39,833	$39,833	—	—	25
10115629_1	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM	$39,205	$39,205	—	—	28
10101318_1	PACEMAKER, DUAL CHAMBER, RATE-RESPONSIVE (IMPLANTABLE)	$39,155	$39,155	—	—	28
10017480_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL/PERONEAL ARTERY(IES); WITH INTRAVASCUL	$38,825	$38,825	—	—	46
10017482_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE	$38,629	$38,629	—	—	46
10120909_1	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chambe	$38,143	$38,143	—	—	46
10104125_1	USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG	$38,130	$38,130	—	—	33
10180291_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH	$37,695	$37,695	—	—	41
10138805_1	CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)	$37,352	$37,352	—	—	28
10138730_10	INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG	$36,743	$36,743	—	—	46
10138730_3	INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG	$36,743	$36,743	—	—	25
10182278_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT	$35,540	$35,540	—	—	41
10116249_1	Insertion of pacemaker pulse generator with existing dual leads	$34,200	$34,200	—	—	46
10013433_1	REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE	$34,017	$34,017	—	—	46
10139918_1	JOINT DEVICE (IMPLANTABLE)	$33,493	$33,493	—	—	28
10039575_1	CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)	$33,356	$33,356	—	—	28
10126583_1	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), NON-RECHARGEABLE	$33,055	$33,055	—	—	28

Showing top 50 of 5,925 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.